Clinical Trial: A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07351903) titled 'A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors' on Jan. 11.

Brief Summary: This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Study Start Date: Oct. 16, 2025

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: GK01 Injection

Autologous tumor-reactive T cells injection

Recruitment Status: RECRUITING

Sponsor: Tianjin Medical University Cancer Institute and Hospital

Disclaimer: Curated by HT Syndication....